Site of oncologic Specialty care for older adolescents in Utah

被引:116
作者
Albritton, Karen H.
Wiggins, Charles H.
Nelson, Harold E.
Weeks, Jane C.
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Utah, Salt Lake City, UT USA
[3] Univ New Mexico, Albuquerque, NM 87131 USA
关键词
D O I
10.1200/JCO.2006.08.4103
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose Adolescents with cancer may access oncologic care from pediatric or adult medical centers, given overlapping age eligibility. However, some recent data suggest a benefit to adolescents with certain cancers when treated at pediatric centers or on pediatric protocols. We used a population-based registry to determine the site of care of children, adolescents, and young adults (age 0 to 24 years) with newly diagnosed cancer. Patients and Methods From the Utah Cancer Registry 1994 to 2000, new malignant cases in patients aged 0 to 24 years were chosen; data including diagnosis, home ZIP code and sites of oncologic care were abstracted. Distance between home ZIP code and Primary Children's Medical Center (PCMC; Salt Lake City, Utah), the state's sole site of pediatric oncology care, was determined. Results Sixty-six percent of Utah 15- to 19-year-olds with cancer were never seen by a PCMC oncologist. Even among this narrow age range, utilization of the pediatric center dropped with each additional year of age. Not unexpectedly, few of those with epithelial malignancies in this age group were seen at PCMC. But surprisingly, 47% of the older adolescents with leukemia, 66% with brain tumors, and 71% with lymphoma never saw a pediatric oncologist. After consideration of age and diagnosis, distance the patient lived from PCMC had a negligible effect on the likelihood of an adolescent being seen there. Conclusion The referral of adolescents with cancer to a pediatric oncology center diminishes greatly with age, and is moderately influenced by diagnosis and minimally by distance from center. Further study should investigate reasons for referral patterns, and impact on outcomes.
引用
收藏
页码:4616 / 4621
页数:6
相关论文
共 29 条
[1]
[Anonymous], 2004, ASH ANN M
[2]
[Anonymous], J PEDIAT HEMATOL ONC
[3]
BERNSTEIN L, 1993, CANCER-AM CANCER SOC, V71, P3222, DOI 10.1002/1097-0142(19930515)71:10+<3222::AID-CNCR2820711712>3.0.CO
[4]
2-V
[5]
Older adolescents with cancer in North America Deficits in outcome and research [J].
Bleyer, A .
PEDIATRIC CLINICS OF NORTH AMERICA, 2002, 49 (05) :1027-+
[6]
National cancer clinical trials: Children have equal access; Adolescents do not [J].
Bleyer, WA ;
Tejeda, H ;
Murphy, SB ;
Robison, LL ;
Ross, JA ;
Pollock, BH ;
Severson, RK ;
Brawley, OW ;
Smith, MA ;
Ungerleider, RS .
JOURNAL OF ADOLESCENT HEALTH, 1997, 21 (06) :366-373
[7]
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials [J].
Boissel, N ;
Auclerc, MF ;
Lhéritier, V ;
Perel, Y ;
Thomas, X ;
Leblanc, T ;
Rousselot, P ;
Cayuela, JM ;
Gabert, J ;
Fegueux, N ;
Piguet, C ;
Huguet-Rigal, F ;
Berthou, C ;
Boiron, JM ;
Poutos, C ;
Michel, G ;
Fière, D ;
Leverger, G ;
Dombret, H ;
Baruchel, A .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) :774-780
[8]
Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands [J].
de Bont, JM ;
van der Holt, B ;
Dekker, AW ;
van der Does-van den Berg, A ;
Sonneveld, P ;
Pieters, R .
LEUKEMIA, 2004, 18 (12) :2032-2035
[9]
Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution [J].
Ferrari, A ;
Gronchi, A ;
Casanova, M ;
Meazza, C ;
Gandola, L ;
Collini, P ;
Lozza, L ;
Bertulli, R ;
Olmi, P ;
Casali, PG .
CANCER, 2004, 101 (03) :627-634
[10]
Rhabdomyosarcoma in adults - A retrospective analysis of 171 patients treated at a single institution [J].
Ferrari, A ;
Dileo, P ;
Casanova, M ;
Bertulli, R ;
Meazza, C ;
Gandola, L ;
Navarria, P ;
Collini, P ;
Gronchi, A ;
Olmi, P ;
Fossati-Bellani, F ;
Casali, PG .
CANCER, 2003, 98 (03) :571-580